Zhang et al. [44] demonstrated that anti-EpCAM BiTE 1H8/CD3 is capable of redirecting T cells to eradicate HCC cells as well as CSCs of HCC in vitro and in vivo. Here, EPCAM is linked to hepatocellular carcinoma.